2013
DOI: 10.1016/j.oooo.2013.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
21
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(24 citation statements)
references
References 35 publications
2
21
1
Order By: Relevance
“…Different researchers have reported increased serum (11 - 15) and salivary (10, 12, 14-16) sialic acid levels in oral cancer patients. Sialic acids are sugar compounds at the end of oligosaccharide chains of glycoproteins and glycolipids, which play an important role in the development of neoplastic behaviors, as important compounds of cell membranes (17).…”
Section: Introductionmentioning
confidence: 97%
“…Different researchers have reported increased serum (11 - 15) and salivary (10, 12, 14-16) sialic acid levels in oral cancer patients. Sialic acids are sugar compounds at the end of oligosaccharide chains of glycoproteins and glycolipids, which play an important role in the development of neoplastic behaviors, as important compounds of cell membranes (17).…”
Section: Introductionmentioning
confidence: 97%
“…Variability in the levels of potential OSCC salivary biomarkers in both non-cancerous individuals and OSCC patients, suggest unknown confounding factors. Without standardization and validation of biomarkers, valuable research resources are being squandered, and the experts in this research ield is needed to discuss this issue and ind a way to establish the standards needed [67]. Salivary biomarkers represent a promising non-invasive approach for oral cancer detection, and an area of strong research interest.…”
Section: Salivary Biomarkersmentioning
confidence: 99%
“…However, some issues (These issues include a lack of standardization for saliva sample collection, processing and storage.) need to be resolved in order to establish this approach as a reliable, highly sensitive and speci ic method for clinical use [67].…”
Section: Salivary Biomarkersmentioning
confidence: 99%
“…The salivary TSA/TP and alpha-L-fucosidase activity were significantly increased in patients with precancerous conditions and cancer compared to the controls (p=0.005 and p=0.001, respectively) [62]. …”
Section: Current State Of Ossc-specific Salivary Biomarkersmentioning
confidence: 99%